See the DrugPatentWatch profile for famciclovir

Based on the available information, there is no evidence to suggest that Famciclovir increases the risk of birth defects. Famciclovir is an antiviral medication used to treat herpes simplex virus infections and varicella-zoster virus infections (such as shingles) [1].

According to the National Library of Medicine's MedlinePlus, Famciclovir is a pregnancy category B drug, which means it is not expected to harm an unborn baby [2]. However, as with any medication, it should only be used during pregnancy if clearly needed.

DrugPatentWatch.com does not have specific information on the risk of birth defects associated with Famciclovir [3].

It is important to note that a patient should always consult with their healthcare provider before starting any new medication, especially during pregnancy. The provider can weigh the potential benefits and risks of the medication and make a recommendation based on the individual's specific circumstances.

Sources:

1. Mayo Clinic. (2021). Famciclovir. Retrieved from <https://www.mayoclinic.org/drugs-supplements/famciclovir-oral-route/side-effects/drg-20062631?p=1>
2. MedlinePlus. (2021). Famciclovir. Retrieved from <https://medlineplus.gov/druginfo/meds/a601145.html>
3. DrugPatentWatch.com. (n.d.). Famciclovir. Retrieved from <https://www.drugpatentwatch.com/drugs/famciclovir>